Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.
Hepatitis B virus (HBV) contains three coterminal envelope proteins on the virion surface: large (L), middle (M), and small (S). The M and S proteins are also secreted as empty "subviral particles," which exceed virions by at least 1,000-fold. The S protein serves as the morphogenic factor for both types of particles, while the L protein is required only for virion formation. We found that cotransfecting replication constructs with a small dose of the expression construct for the missing L, M, and S proteins reconstituted efficient virion secretion but only 5 to 10% of subviral particles. The L protein inhibited secretion of subviral particles in a dose-dependent manner, whereas a too-high or too-low L/S protein ratio inhibited virion secretion. Consistent with the results of cotransfection experiments, a point mutation at the -3 position of the S gene AUG codon reduced HBsAg secretion by 60 to 70% but maintained efficient virion secretion. Surprisingly, ablating M protein expression reduced virion secretion but markedly increased the maturity of virion-associated genomes, which could be reversed by providing in trans both L and M proteins but not just M protein. M protein stability was dependent on the coexpression of S protein. Our findings suggest that efficient HBV virion secretion could be maintained despite drastic reduction in subviral particle production, which supports the recent demonstration of separate secretion pathways adopted by the two types of particles. The M protein appears to facilitate core particle envelopment, thus shortening the window of plus strand DNA elongation.
Garcia
Tamako
T
Graduate Program in Pathobiology, Division of Biology and Medicine, Brown University, Providence, Rhode Island, USA.
Li
Jisu
J
Sureau
Camille
C
Ito
Kiyoaki
K
Qin
Yanli
Y
Wands
Jack
J
Tong
Shuping
S
D000818:Animals; D002460:Cell Line; D004279:DNA, Viral; D006515:Hepatitis B virus / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D006801:Humans; D010316:Particle Size; D011401:Promoter Regions, Genetic; D055571:Secretory Pathway / Q000502:physiology; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D014763:Viral Matrix Proteins / Q000235:genetics / Q000378:metabolism*; D014771:Virion / Q000378:metabolism* / Q000648:ultrastructure
D004279:DNA, Viral; C096362:L protein, hepatitis B virus; D014759:Viral Envelope Proteins; D014763:Viral Matrix Proteins
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1059-63
1992457
J Cell Biol. 1992 Sep;118(6):1305-20
1522109
World J Gastroenterol. 2007 Jan 7;13(1):48-64
17206754
J Virol. 1998 Jul;72(7):5573-8
9621015
J Virol. 1994 Mar;68(3):1564-72
8107218
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10205-10
17551004
J Virol. 2007 Sep;81(17):9050-60
17553870
J Virol. 1993 Dec;67(12):7414-22
8230462
Science. 1986 Dec 12;234(4782):1388-91
3787251
J Virol. 1987 Mar;61(3):782-6
3806798
Cell. 1982 Jun;29(2):403-15
6180831
J Virol. 1987 May;61(5):1384-90
2437317
J Virol. 1994 Jul;68(7):4341-8
8207809
Virology. 2009 May 10;387(2):364-72
19327810
J Virol. 1998 Feb;72(2):1462-8
9445049
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2235-9
8134380
Virology. 1993 May;194(1):137-48
8480417
Virology. 2005 Feb 5;332(1):216-24
15661154
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9338-42
3467308
Hepatology. 2003 Nov;38(5):1075-86
14578844
Virology. 1992 Jun;188(2):948-52
1585662
Cell. 1986 Nov 7;47(3):451-60
3768961
J Virol. 2007 Feb;81(4):1641-9
17135319
J Virol. 1984 Jul;51(1):181-91
6328037
J Virol. 2003 Jun;77(12):6601-12
12767980
J Biol Chem. 2006 Sep 29;281(39):29297-308
16867982
Microbiol Mol Biol Rev. 2000 Mar;64(1):51-68
10704474
J Virol. 2004 Dec;78(23):13122-31
15542664
Virology. 1995 Nov 10;213(2):292-9
7491754
J Gen Virol. 2008 Nov;89(Pt 11):2882-2890
18931087
J Immunol Methods. 1980;35(3-4):307-18
6156971
J Virol. 1986 Dec;60(3):880-7
3783819
Clin Exp Immunol. 1991 Jun;84(3):493-500
2044231
Virus Res. 2004 Dec;106(2):199-209
15567498
J Biol Chem. 2003 Jul 25;278(30):28123-9
12740387
J Virol. 1996 Jul;70(7):4269-74
8676448
J Virol. 1998 Jan;72(1):778-82
9420286
Mol Cell. 2009 Jun 12;34(5):545-55
19524535
J Virol. 2006 Jan;80(2):587-95
16378961
J Virol. 2001 Jun;75(11):5343-51
11333915
Cell. 1986 Jan 31;44(2):283-92
3943125
J Virol. 2007 Apr;81(8):3842-51
17267490
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1822-7
9050863
Front Biosci (Landmark Ed). 2009 Jan 01;14:1606-18
19273150
Clin Exp Immunol. 1988 Apr;72(1):164-7
3396217
J Virol. 1987 Jul;61(7):2280-5
3586133
J Virol. 1992 Sep;66(9):5682-4
1501300
J Virol. 2007 Sep;81(17):9202-15
17567705
J Virol. 2008 Aug;82(16):7812-7
18524834
N Engl J Med. 2004 Mar 11;350(11):1118-29
15014185
J Virol. 2006 Dec;80(24):11935-45
17020942
J Virol. 2004 Apr;78(7):3262-70
15016847
J Virol. 1996 Jan;70(1):133-40
8523517
J Virol. 1994 Jun;68(6):4063-6
8189544
J Virol. 1997 Dec;71(12):9350-7
9371594
Virology. 1995 Nov 10;213(2):660-5
7491790
J Virol. 2009 Feb;83(4):1579-91
19052077